Christine R. J.
- Country
- France
- Department
- Gynecologie médicale
Research Overview
- Efficacy and Safety of Elinzanetant in Treating Vasomotor Symptoms Induced by Adjuvant Endocrine Therapy in Hormone-Receptor Positive Breast Cancer Patients
- Efficacy and Safety of Fezolinetant in Treating Vasomotor Symptoms in Hormone Receptor-Positive Breast Cancer Patients on Adjuvant Endocrine Therapy
- Multicenter, randomized, double-blinded, placebo-controlled phase 3 trial to evaluate nonavalent HPV vaccine as a secondary prevention in patients treated for human papilloma virus related high-grade squamous intraepithelial lesions.(BioHPV)
Data & Insights
Has run more than one trial at 13 of 150 partner sites.
Specializations
Women's Health and Oncology
This investigator specializes in managing vasomotor symptoms (VMS) in women undergoing treatment for hormone receptor-positive breast cancer. Their research encompasses therapeutic approaches for patients experiencing treatment-related side effects.
- Breast Cancer Management
- Endocrine Therapy Complications
- Hot Flash Treatment
Therapeutic Innovation
The investigator focuses on developing treatments for endocrine therapy-induced symptoms, particularly exploring novel compounds for managing moderate to severe hot flashes in cancer patients.
- Symptom Management
- Quality of Life Improvement
- Treatment Side Effects
Preventive Medicine
Their expertise extends to preventive care for women at high risk for developing hormone-receptor positive breast cancer, with particular attention to managing treatment-related vasomotor symptoms.
- Risk Assessment
- Preventive Strategies
- Supportive Care
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.